The cancer treatment landscape faces a critical challenge: a market structure where a limited number of pharmaceutical giants control the supply and pricing of essential therapies. This dynamic restricts patient access due to exorbitant costs and stifles innovation by blocking generic competition. While shareholders and executives benefit from immense profits, patients and healthcare systems bear the financial burden, creating a significant barrier to equitable, life-saving care.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends